Journal of Molecular Immunology
Open Access

Immunogenicity of biopharmaceuticals

Search results for
Immunogenicity of biopharmaceuticals

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Immunogenicity of biopharmaceuticals

Immune response by biopharmaceuticals agents are increasing greatly. The first generation of such products were of non-human origin, such as bovine-insulin, streptokinase or staphylokinase. The more recent preparations include human recombinant DNA products, such as interferon (IFN)α 2a, IFNβ, erythropoietin, insulin and growth hormone.

Related Journals of Immunogenicity of biopharmaceuticals
Journal of Molecular Immunology, Clinical & Medical Genomics Open Access, Pharmacogenomics & Pharmacoproteomics Open Access, Proteomics & Bioinformatics Open Access, Proteomics & Enzymology Hybrid Open Access, International Journal of Applied Biology and Pharmaceutical Technology Open Access, Journal of Pharmaceutical Microbiology, Clinical & Medical Genomics Open Access, The New England Journal of Medicine, Journal of General Virology, Journal of Medical Microbiology

Immunogenicity of biopharmaceuticals

Expert PPTs

Speaker PPTs

Conference Proceedings